researchers from The universities of Toronto and McMaster have tested a new treatment on mice that has improved their life expectancy, and reduced their tumor.
researchers from The universities of Toronto and McMaster have tested a new treatment on mice that has improved their life expectancy, and reduced their tumor.
This is one of the brain tumors the most lethal and most frequent in men. Glioblastoma multiforme (GBM) leaves very little chance of survival to the affected individual. But the situation could change.
READ ALSO >> An artificial intelligence will detect tumors of the brain in real time
researchers from The universities of Toronto and McMaster would be able to establish a treatment and the first results are encouraging, reports Futura Sciences. In normal times, the patients in the GBM do not survive beyond a year. Only 3% of them live up to five years after being diagnosed. The number of dead around each year the 241 000 in the world.
Your support is essential. Subscribe for $ 1 support Us
First clinical trials on the horizon 2022
The T-lymphocyte, present in human blood, have the ability to recognize cancer cells or infected in order to kill them. Scientists have developed a molecule genetically modified and grown in the laboratory from the T lymphocytes of the patient to allow them to continue destroying hiv-infected cells, and this in spite of the presence of the cancer that would modify the immune response. The first tests have been carried out in a group of mice.
READ ALSO >> The artificial intelligence, best friend of the doctors?
The guinea pigs exhibited a reduction of tumor burden, and their life expectancy has improved. These early promises are materialised by the creation of the start-up Empirica Therapeutics. This last has set a goal to launch the first clinical trials on the horizon 2022. Other tests should then follow.
Read our complete file
cancer
The fatality risk of the Covid-19 is two-fold higher in the cancer The League against cancer provides recommendations against the coronavirus Coronavirus: when the race for the vaccine that helps to fight cancer
READ ALSO >> Hugues Duffau: “The brain repairs itself”
“We hope that our approach to target the cells of the glioblastoma by using the therapy CAR-T will provide the patients a better quality of life and chances of survival more important”, explains to Future Science Jason Moffat, scientific officer at Empirica Therapeutics.
Date Of Update: 02 June 2020, 10:58
Categories: Optical Illusion
Source: newstars.edu.vn